FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048874328> ?p ?o ?g. }

• W3048874328 endingPage "6569" @default.
• W3048874328 startingPage "6562" @default.
• W3048874328 abstract "New influenza vaccine formulations are designed to improve vaccine effectiveness and protect those most vulnerable to infection. High dose trivalent inactivated influenza vaccine (HD-IIV3), licensed for ages ≥65 years, produces greater antibody responses and efficacy in clinical trials, but post-licensure vaccine effectiveness (VE) compared to standard dose (SD-IIV3/4) vaccine remains an open question.Using a test-negative, case control design and propensity analyses to adjust for confounding, US Influenza VE Network data from the 2015-2016 through 2018-2019 seasons were analyzed to determine relative VE (rVE) between HD-IIV3 and SD-IIV3/4 among outpatients ≥65 years old presenting with acute respiratory illness. Influenza vaccination status was derived from electronic medical records and immunization registries.Among 3861 enrollees, 2993 (78%) were vaccinated; 1573 (53%) received HD-IIV3 and 1420 (47%) received SD-IIV3/4. HD-IIV3 recipients differed from SD-IIV3/4 recipients by race, previous vaccination, number of outpatient visits in the previous year and timing of vaccination, and were balanced in the propensity model except the timing of vaccination. Compared with no vaccination, significant protection against any influenza A was observed from both HD-IIV3 (VE = 29%; 95%CI = 10%, 44%) and SD-IIV3/4 (VE = 24%; 95%CI = 5%, 39%); rVE = 18% (95%CI = 0%, 33%, SD as referent). When stratified by virus type, against A/H1N1, HD-IIV3 VE was 30% (95%CI = -7%, 54%), SD-IIV3/4 VE was 40% (95%CI = 10%, 61%), and rVE = -32%; (95%CI = -94%, 11%); Against A/H3N2, HD-IIV3 VE was 31% (95%CI = 9%, 47%), SD-IIV3/4 VE was 19% (95%CI = -5%, 37%), and rVE = 27%; (95% CI = 9%, 42%).Among adults ≥65 years of age, recipients of standard and high dose influenza vaccines differed significantly in their characteristics. After adjusting for these differences, high dose vaccine offered more protection against A/H3N2 and borderline significant protection against all influenza A requiring outpatient care during the 2015-2018 influenza seasons." @default.
• W3048874328 created "2020-08-18" @default.
• W3048874328 creator A5007966612 @default.
• W3048874328 creator A5010848966 @default.
• W3048874328 creator A5011537093 @default.
• W3048874328 creator A5020891630 @default.
• W3048874328 creator A5022713628 @default.
• W3048874328 creator A5053417709 @default.
• W3048874328 creator A5055554681 @default.
• W3048874328 creator A5056332480 @default.
• W3048874328 creator A5064470464 @default.
• W3048874328 creator A5067426689 @default.
• W3048874328 creator A5072798118 @default.
• W3048874328 creator A5079482621 @default.
• W3048874328 creator A5081494304 @default.
• W3048874328 creator A5081844185 @default.
• W3048874328 creator A5083860011 @default.
• W3048874328 creator A5087750390 @default.
• W3048874328 creator A5090955836 @default.
• W3048874328 date "2020-09-01" @default.
• W3048874328 modified "2023-09-30" @default.
• W3048874328 title "Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015–16 to 2018–19" @default.
• W3048874328 cites W159261423 @default.
• W3048874328 cites W2001187841 @default.
• W3048874328 cites W2015260696 @default.
• W3048874328 cites W2048470090 @default.
• W3048874328 cites W2060654063 @default.
• W3048874328 cites W2072656136 @default.
• W3048874328 cites W2085474162 @default.
• W3048874328 cites W2095196265 @default.
• W3048874328 cites W2104962277 @default.
• W3048874328 cites W2121744293 @default.
• W3048874328 cites W2139577967 @default.
• W3048874328 cites W2140126081 @default.
• W3048874328 cites W2143416241 @default.
• W3048874328 cites W2168805652 @default.
• W3048874328 cites W2170249205 @default.
• W3048874328 cites W2347141020 @default.
• W3048874328 cites W2516193022 @default.
• W3048874328 cites W2591695960 @default.
• W3048874328 cites W2606900230 @default.
• W3048874328 cites W2744482235 @default.
• W3048874328 cites W2766960916 @default.
• W3048874328 cites W2791799763 @default.
• W3048874328 cites W2792196997 @default.
• W3048874328 cites W2891230562 @default.
• W3048874328 cites W2899816568 @default.
• W3048874328 cites W2904715936 @default.
• W3048874328 cites W2912473805 @default.
• W3048874328 cites W2982405140 @default.
• W3048874328 cites W3006823364 @default.
• W3048874328 cites W3007037952 @default.
• W3048874328 cites W4297791620 @default.
• W3048874328 cites W4301377495 @default.
• W3048874328 doi "https://doi.org/10.1016/j.vaccine.2020.08.011" @default.
• W3048874328 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7508973" @default.
• W3048874328 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32800465" @default.
• W3048874328 hasPublicationYear "2020" @default.
• W3048874328 type Work @default.
• W3048874328 sameAs 3048874328 @default.
• W3048874328 citedByCount "14" @default.
• W3048874328 countsByYear W30488743282021 @default.
• W3048874328 countsByYear W30488743282022 @default.
• W3048874328 countsByYear W30488743282023 @default.
• W3048874328 crossrefType "journal-article" @default.
• W3048874328 hasAuthorship W3048874328A5007966612 @default.
• W3048874328 hasAuthorship W3048874328A5010848966 @default.
• W3048874328 hasAuthorship W3048874328A5011537093 @default.
• W3048874328 hasAuthorship W3048874328A5020891630 @default.
• W3048874328 hasAuthorship W3048874328A5022713628 @default.
• W3048874328 hasAuthorship W3048874328A5053417709 @default.
• W3048874328 hasAuthorship W3048874328A5055554681 @default.
• W3048874328 hasAuthorship W3048874328A5056332480 @default.
• W3048874328 hasAuthorship W3048874328A5064470464 @default.
• W3048874328 hasAuthorship W3048874328A5067426689 @default.
• W3048874328 hasAuthorship W3048874328A5072798118 @default.
• W3048874328 hasAuthorship W3048874328A5079482621 @default.
• W3048874328 hasAuthorship W3048874328A5081494304 @default.
• W3048874328 hasAuthorship W3048874328A5081844185 @default.
• W3048874328 hasAuthorship W3048874328A5083860011 @default.
• W3048874328 hasAuthorship W3048874328A5087750390 @default.
• W3048874328 hasAuthorship W3048874328A5090955836 @default.
• W3048874328 hasBestOaLocation W30488743282 @default.
• W3048874328 hasConcept C126322002 @default.
• W3048874328 hasConcept C203014093 @default.
• W3048874328 hasConcept C22070199 @default.
• W3048874328 hasConcept C2780689484 @default.
• W3048874328 hasConcept C3020110884 @default.
• W3048874328 hasConcept C71924100 @default.
• W3048874328 hasConcept C77350462 @default.
• W3048874328 hasConceptScore W3048874328C126322002 @default.
• W3048874328 hasConceptScore W3048874328C203014093 @default.
• W3048874328 hasConceptScore W3048874328C22070199 @default.
• W3048874328 hasConceptScore W3048874328C2780689484 @default.
• W3048874328 hasConceptScore W3048874328C3020110884 @default.
• W3048874328 hasConceptScore W3048874328C71924100 @default.
• W3048874328 hasConceptScore W3048874328C77350462 @default.
• W3048874328 hasFunder F4320309652 @default.

• next